Energia i regulacje · 3.02.2023
SHINE Technologies, LLC; SHINE Medical Isotope Production Facility
The U.S. Nuclear Regulatory Commission (NRC) is considering issuance of an amendment to Construction Permit No. CPMIF-001, issued to SHINE Technologies, LLC (SHINE, the licensee), for the construction of the SHINE Medical Isotope Production Facility. The proposed amendment would allow the receipt and possession of contained special nuclear material for the continued construction of the SHINE Medical Isotope Production Facility.